SLC40A1 and plasma cell myeloma: In myeloma cells, Nrf2 directly trans-activates FPN1 or promotes FPN1 expression by inhibiting miR-17-5p, promoting iron export, reducing the intracellular ferric ion concentration and ROS production, and inhibiting ferroptosis [73].